Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Canntab Therapeutics Limited C.TFS

Healthcare Metals & Mining Drug Manufacturers - Major Industrial Metals & Minerals
"Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for... see more

Recent & Breaking News (CSE:TFS)

Canntab to Commence Trading on CSE on 4/20

Newsfile April 19, 2018

Canntab Therapeutics Announces Completion of Amalgamation with Telferscot Resources

Newsfile April 12, 2018

CORRECTION FROM SOURCE: Telferscot to Distribute Equity in Seven New Companies to TFS Shareholders

Newsfile April 5, 2018

Telferscot Receives Final Approvals to Proceed with Acquisition of Canntab Therapeutics

Newsfile April 3, 2018

Telferscot to Distribute Equity in Seven New Companies to TFS Shareholders

Newsfile April 3, 2018

Telferscot Shareholders Approve Transactions

Newsfile March 23, 2018

Telferscot Shareholder Meeting and Canntab Acquisition Update

Newsfile March 1, 2018

Telferscot and Canntab Therapeutics Execute Definitive Agreement

GlobeNewswire January 15, 2018

IIROC Trading Halt - TFS

Canada NewsWire January 15, 2018

Telferscot Provides Update on LOI with Canntab

GlobeNewswire December 19, 2017

IIROC Trade Resumption - TFS

Canada NewsWire November 28, 2017

Telferscot Provides Clarification on LOI with Canntab

MarketWire Canada November 28, 2017

IIROC Trading Halt - TFS

Canada NewsWire November 28, 2017

Telferscot Signs Letter of Intent with Canntab Therapeutics Limited

GlobeNewswire November 27, 2017

Telferscot Signs Letter of Intent with Firegold Company Ltd.

MarketWire Canada May 29, 2017

Telferscot Resources Closes Private Placement

MarketWire Canada May 11, 2017

Telferscot Resources Announces Private Placement

MarketWire Canada April 25, 2017

Telferscot Resources Announces Termination of Agreement

MarketWire Canada January 5, 2017

Telferscot Signs Extension Agreement With Auxico Resources and Grants Options

MarketWire Canada October 5, 2016

Telferscot Extends Letter of Intent With Auxico

MarketWire Canada June 16, 2016